Iacopetta B - Search Results

1

Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients.

Powell BL, Bydder S, Grieu F, Gnanasampanthan G, Elsaleh H, Seshadri R, Berns EM, Iacopetta B. Powell BL, et al. Among authors: iacopetta b. Breast Cancer Res Treat. 2001 Sep;69(1):65-8. doi: 10.1023/a:1012233509663. Breast Cancer Res Treat. 2001. PMID: 11759829

2

Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer.

Wang C, van Rijnsoever M, Grieu F, Bydder S, Elsaleh H, Joseph D, Harvey J, Iacopetta B. Wang C, et al. Among authors: iacopetta b. Oncology. 2003;64(3):259-65. doi: 10.1159/000069311. Oncology. 2003. PMID: 12697967

3

Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype.

Grieu F, Powell B, Beilby J, Iacopetta B. Grieu F, et al. Among authors: iacopetta b. Anticancer Res. 2004 Sep-Oct;24(5B):3215-9. Anticancer Res. 2004. PMID: 15510613 Free article.

4

Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.

Grieu F, Li WQ, Iacopetta B. Grieu F, et al. Among authors: iacopetta b. Breast Cancer Res Treat. 2004 Dec;88(3):197-204. doi: 10.1007/s10549-004-0595-6. Breast Cancer Res Treat. 2004. PMID: 15609121

5

PIK3CA mutations in breast cancer are associated with poor outcome.

Li SY, Rong M, Grieu F, Iacopetta B. Li SY, et al. Among authors: iacopetta b. Breast Cancer Res Treat. 2006 Mar;96(1):91-5. doi: 10.1007/s10549-005-9048-0. Epub 2005 Nov 30. Breast Cancer Res Treat. 2006. PMID: 16317585

6

Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer.

Powell BL, van Staveren IL, Roosken P, Grieu F, Berns EM, Iacopetta B. Powell BL, et al. Among authors: iacopetta b. Carcinogenesis. 2002 Feb;23(2):311-5. doi: 10.1093/carcin/23.2.311. Carcinogenesis. 2002. PMID: 11872638

7

Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.

Iacopetta B, Grieu F, Powell B, Soong R, McCaul K, Seshadri R. Iacopetta B, et al. Clin Cancer Res. 1998 Jul;4(7):1597-602. Clin Cancer Res. 1998. PMID: 9676832

8

P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomas.

Elsaleh H, Soontrapornchai P, Grieu F, Joseph D, Iacopetta B. Elsaleh H, et al. Among authors: iacopetta b. Int J Oncol. 1999 Dec;15(6):1239-43. doi: 10.3892/ijo.15.6.1239. Int J Oncol. 1999. PMID: 10568834

9

p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma.

Elsaleh H, Powell B, Soontrapornchai P, Joseph D, Goria F, Spry N, Iacopetta B. Elsaleh H, et al. Among authors: iacopetta b. Oncology. 2000;58(1):52-9. doi: 10.1159/000012079. Oncology. 2000. PMID: 10644941

10

TP53 gene mutation status in pretreatment biopsies of oesophageal adenocarcinoma has no prognostic value.

Soontrapornchai P, Elsaleh H, Joseph D, Hamdorf JM, House AK, Iacopetta B. Soontrapornchai P, et al. Among authors: iacopetta b. Eur J Cancer. 1999 Nov;35(12):1683-7. doi: 10.1016/s0959-8049(99)00172-0. Eur J Cancer. 1999. PMID: 10674013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters